Literature DB >> 15086871

Otilonium bromide inhibits muscle contractions via L-type calcium channels in the rat colon.

M T Martin1, L Hove-Madsen, M Jimenez.   

Abstract

The aim of this study is to evaluate in vitro the effect of otilonium bromide (OB) on the mechanical and electrical activities of the rat colonic smooth muscle using muscle bath, microelectrodes and patch-clamp techniques. Otilonium bromide dose dependently inhibited the spontaneous activity (logIC(50) +/- SE: -5.31 +/- 0.05). This effect was not modified by TTX (10(-6) mol L(-1)). Cyclic depolarizations were abolished by OB (10(-4) mol L(-1)). Electrical field stimulation induced inhibitory junction potentials (IJPs) followed by a depolarization with superimposed spikes causing a contraction. In the presence of OB (10(-4) mol L(-1)) IJPs were recorded, but spikes and contractions were abolished. Otilonium bromide (3 x 10(-6) mol L(-1)) inhibited inward current obtained in isolated cells (amphotericin perforated patch technique). The otilonium-sensitive current amplitude was maximal (75pA) around 0 mV. The effect of different doses of OB was tested by depolarizing cells from -70 mV to 0 mV. OB dose dependently inhibited the inward current with an EC(50) of 885 nmol L(-1). Abolishment of the otilonium-sensitive current by 3 x 10(-6) mol L(-1) nifedipine confirmed that it was an L-type Ca(2+) current. Our results show that OB inhibits the spontaneous and triggered muscular contractions. This effect is produced by the inhibition of muscular action potentials carried by L-type calcium current, confirming the spasmolytic properties of OB.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086871     DOI: 10.1111/j.1365-2982.2004.00518.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  9 in total

1.  Changes in nitrergic and tachykininergic pathways in rat proximal colon in response to chronic treatment with otilonium bromide.

Authors:  G Cipriani; S J Gibbons; S A Saravanaperumal; J Malysz; L Sha; J H Szurszewski; D R Linden; S Evangelista; M S Faussone-Pellegrini; M G Vannucchi; G Farrugia
Journal:  Neurogastroenterol Motil       Date:  2015-04-30       Impact factor: 3.598

2.  Effects of hydrogen sulphide on motility patterns in the rat colon.

Authors:  V Gil; Sp Parsons; D Gallego; Jd Huizinga; M Jimenez
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

3.  T-type Ca(2+) channel modulation by otilonium bromide.

Authors:  Peter R Strege; Lei Sha; Arthur Beyder; Cheryl E Bernard; Edward Perez-Reyes; Stefano Evangelista; Simon J Gibbons; Joseph H Szurszewski; Gianrico Farrugia
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-04       Impact factor: 4.052

4.  Tiotropium bromide inhibits TGF-β-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro.

Authors:  Kazuhito Asano; Yusuke Shikama; Naruo Shoji; Kojiro Hirano; Harumi Suzaki; Hiroaki Nakajima
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-09-07

Review 5.  Colonic smooth muscle cells and colonic motility patterns as a target for irritable bowel syndrome therapy: mechanisms of action of otilonium bromide.

Authors:  Jakub Rychter; Francisco Espín; Diana Gallego; Patri Vergara; Marcel Jiménez; Pere Clavé
Journal:  Therap Adv Gastroenterol       Date:  2014-07       Impact factor: 4.409

6.  Inner and outer portions of colonic circular muscle: ultrastructural and immunohistochemical changes in rat chronically treated with otilonium bromide.

Authors:  Chiara Traini; Maria Simonetta Faussone-Pellegrini; Stefano Evangelista; Katia Mazzaferro; Gianluca Cipriani; Paolo Santicioli; Maria Giuliana Vannucchi
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

7.  Repeated otilonium bromide administration prevents neurotransmitter changes in colon of rats underwent to wrap restraint stress.

Authors:  Chiara Traini; Stefano Evangelista; Vincent Girod; Maria Simonetta Faussone-Pellegrini; Maria Giuliana Vannucchi
Journal:  J Cell Mol Med       Date:  2016-11-20       Impact factor: 5.310

8.  Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro.

Authors:  Kazuhito Asano; Yusuke Shikama; Yasuhiro Shibuya; Hiroaki Nakajima; Ken-ichi Kanai; Naohiro Yamada; Harumi Suzaki
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 9.  Long-term efficacy and safety of otilonium bromide in the management of irritable bowel syndrome: a literature review.

Authors:  John K Triantafillidis; George Malgarinos
Journal:  Clin Exp Gastroenterol       Date:  2014-04-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.